Biotech Values

[DewDiligence]

[OT] rph_in_wi: I have two questions about ordinary, short-release (not XL) Adderall that you might be able to answer. A few months ago, BRL acquired Shire’s branded Adderall business for $63M (#msg-12664107). However, BRL was already selling a generic version of Adderall when they struck this deal.

1. Does BRL now furnish two different Adderall lines: the “branded” line they got from Shire as well as their own generic line?

2. If yes, is there a difference in efficacy that you are aware of based on customer feedback or other sources?

T.i.a. Dew